Please Wait
Applying Filters...
Menu
Xls

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20240223169844/en

BUSINESSWIRE
23 Feb 2024

https://www.businesswire.com/news/home/20240220917017/en

BUSINESSWIRE
20 Feb 2024

https://www.businesswire.com/news/home/20240109280483/en

BUSINESSWIRE
09 Jan 2024

https://www.prnewswire.com/news-releases/everest-medicines-announces-china-center-for-drug-evaluation-of-nmpa-recommends-priority-review-for-cefepime-taniborbactam-for-the-treatment-of-complicated-urinary-tract-infections-including-pyelonephritis-301932731.html

PR NEWSWIRE
19 Sep 2023

https://www.businesswire.com/news/home/20230815163087/en

BUSINESSWIRE
15 Aug 2023

https://www.prnewswire.com/news-releases/everest-medicines-partner-venatorx-receives-fda-acceptance-and-priority-review-of-new-drug-application-for-cefepime-taniborbactam-to-treat-complicated-urinary-tract-infections-cuti-301900949.html

PR NEWSWIRE
15 Aug 2023